Phase I Study to Evaluate the Safety and Tolerability of ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

Next Previous
Trial Profile

Phase I Study to Evaluate the Safety and Tolerability of ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Feb 2018

At a glance

  • Drugs Varlitinib (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Oxaliplatin
  • Indications Solid tumours
  • Focus Adverse reactions

    • Most Recent Events

    • 01 Feb 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.
    • 12 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top